Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.39 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | PDE5A | O76074 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5000164 | 0.84 | DHODH (0.60) | DHODHCYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL9668298 | 0.83 | PDE10A (0.47) | DHODHCYP2D6CYP2C19PDE10ALMNA | |
| SCHEMBL3535265 | 0.77 | TBXAS1 (0.42) | DHODHCYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL1424751 | 0.76 | CYP19A1 (0.47) | CYP3A4FAAHMGLLTBXAS1CYP24A1 | |
| SCHEMBL5467914 | 0.76 | DHODH (0.41) | DHODHCYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL10118094 | 0.75 | ALDH1A1 (0.54) | CYP1A2CYP3A4CYP2D6CYP2C19LMNA | |
| SCHEMBL5449147 | 0.75 | ALDH1A1 (0.54) | DHODHCYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL30366356 | 0.74 | FAAH (0.44) | CYP3A4FAAHMGLLLMNAALDH1A1 | |
| SCHEMBL31388141 | 0.74 | MGAM (0.51) | MAPK1TP53ALDH1A1TSHR | |
| Quinoline SCHEMBL27690684 | 0.74 | ALDH1A1 (0.47) | CYP3A4FAAHMGLLALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10696899-B2 | Light emitting shell in multi-compartment microcapsules | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2020-06-30 | — | — | US | disclosed |
| US-20180327659-A1 | LIGHT EMITTING SHELL IN SHELL MICROCAPSULES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2018-11-15 | — | — | US | disclosed |
| US-7718576-B2 | Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein | WALDROP III ALEXANDER A | 2010-05-18 | — | — | US | disclosed |
| EP-1019379-B1 | PEROXIDE-BASED CHEMILUMINESCENT ASSAYS AND CHEMILUMINESCENT COMPOUNDS USED THEREIN | MAINE MEDICAL CT (US) | 2005-10-19 | — | — | EP | disclosed |
| US-20030219844-A1 | Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein | MAINE MEDICAL CENTER | 2003-11-27 | — | — | US | disclosed |
| EP-1019379-A4 | PEROXIDE-BASED CHEMILUMINESCENT ASSAYS AND CHEMILUMINESCENT COMPOUNDS USED THEREIN | MAINE MEDICAL CT (US) | 2001-07-04 | — | — | EP | disclosed |
| EP-1019379-A1 | PEROXIDE-BASED CHEMILUMINESCENT ASSAYS AND CHEMILUMINESCENT COMPOUNDS USED THEREIN | Maine Medical Center (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999009012-A1 | PEROXIDE-BASED CHEMILUMINESCENT ASSAYS AND CHEMILUMINESCENT COMPOUNDS USED THEREIN | MAINE MEDICAL CENTER (US) | 1999-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030219844-A1 | Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein | CBR1, CBR3, NR2E3 | DHODH 2557/4885CYP1A2 415/4885CYP3A4 345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.